Viewing Study NCT04701333


Ignite Creation Date: 2025-12-25 @ 3:02 AM
Ignite Modification Date: 2025-12-26 @ 1:42 AM
Study NCT ID: NCT04701333
Status: COMPLETED
Last Update Posted: 2024-02-13
First Post: 2021-01-06
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss
Sponsor: Stanford University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-04-01
Start Date Type: ACTUAL
Primary Completion Date: 2022-06-24
Primary Completion Date Type: ACTUAL
Completion Date: 2023-03-01
Completion Date Type: ACTUAL
First Submit Date: 2021-01-06
First Submit QC Date: None
Study First Post Date: 2021-01-08
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-03-13
Results First Submit QC Date: None
Results First Post Date: 2023-04-05
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-01-19
Last Update Post Date: 2024-02-13
Last Update Post Date Type: ACTUAL